ADIPOQ and metabolic syndrome: Yoon et al. investigated obesity-linked metabolic dysregulation and showed that hypoadiponectinemia is independently associated with the presence of metabolic syndrome in CKD patients, which is definite evidence of the relationship of adiponectin with kidney function[10].